Opioids Market Size, Share & Trends Analysis Report By Product, By Application (Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction), By Region, And Segment Forecasts, 2018 - 2025

  • ID: 4538721
  • Report
  • 113 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Allergan Plc (Actavis)
  • Egalet Corporation
  • Pfizer, Inc.
  • Purdue Pharma L.P.
  • Sanofi-Aventis S.A.
  • MORE
The global opioids market size is estimated to reach USD 34.96 billion by 2025, exhibiting a CAGR of 4.8% during the forecast period. Growing geriatric population, coupled with increasing focus on palliative care, is estimated to boost the market. Moreover, increasing number of acquisitions and collaborations by market players is expected to drive growth.

Furthermore, rising prevalence of disease conditions with chronic pain, such as cancer, lower back pain, arthritis, and fibromyalgia is driving the market. Substantial rise in road accidents and trauma, coupled with constantly increasing cases of surgical procedures, is also driving demand for opioid-based pain management solutions.

North America is leading the opioids market with a share of over 56.0% in 2016. One of the major reasons for its dominance is rising geriatric population with terminal conditions, such as rheumatoid arthritis. However, opioid abuse in U.S. has been rising at an alarming rate. Overdose of opioids has killed over 28,000 people in 2014 alone. Almost half of those deaths were caused by prescription opioids. Hence, opioid abuse has been declared a “public health emergency” in U.S., and this is likely to limit the growth of opioids in North America.

Further key findings from the report suggest:
  • Extended release opioids were the largest product segment in 2016 due to its high usage in chronic pain management
  • Anesthesia is estimated to be the fastest growing application segment over the forecast period due to factors such as safety and high drug efficacy
  • Cancer pain was the largest pain relief segment in 2016 owing to global increase in prevalence of cancer
  • North America was the largest region in 2016 owing to local presence of key players and increasing adoption of opioids for pain management
  • Europe was the second-largest segment in 2016 due to factors such rising geriatric population
  • Asia Pacific is expected to witness fastest growth over the forecast period due to increase in geriatric population, coupled with increase in focus on palliative care
  • Some of the key players are Purdue Pharma L.P; West-Ward Pharmaceuticals Corporation; Allergan; Pfizer, Inc.; Janssen Pharmaceuticals, Inc.; Egalet Corporation; and Sun Pharmaceutical Industries Limited
  • Most key players are focusing on entering untapped regions and expanding their product portfolios.


PLEASE NOTE:
This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc (Actavis)
  • Egalet Corporation
  • Pfizer, Inc.
  • Purdue Pharma L.P.
  • Sanofi-Aventis S.A.
  • MORE
Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 Internal database
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Expanding application of opioids in various therapeutic conditions
3.2.2 Expanding target audience for the opioid market
3.2.3 Formulation of opioids switching from immediate to extended-release forms
3.3 Market restraint analysis
3.3.1 Stringent regulatory framework
3.3.2 Opioid abuse and dependency
3.4 Penetration & growth prospect mapping
3.5 Global opioids Market - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s

Chapter 4 Global Opioids Market: Product Estimates & Trend Analysis
4.1 Global opioids market by product, movement analysis
4.2 Immediate-Release/Short-Acting Opioid
4.2.1 Immediate-release/short-acting opioid market estimates and forecast, 2014 - 2025 (USD Billion)
4.2.2 Codeine market estimates and forecast, 2014 - 2025 (USD Billion)
4.2.3 Oxycodone market estimates and forecast, 2014 - 2025 (USD Billion)
4.2.4 Hydrocodone market estimates and forecast, 2014 - 2025 (USD Billion)
4.2.5 Fentanyl market estimates and forecast, 2014 - 2025 (USD Billion)
4.2.6 Morphine market estimates and forecast, 2014 - 2025 (USD Billion)
4.2.7 Hydroxymorphone market estimates and forecast, 2014 - 2025 (USD Billion)
4.2.8 Oxymorphone market estimates and forecast, 2014 - 2025 (USD Billion)
4.2.9 Propoxyphene market estimates and forecast, 2014 - 2025 (USD Billion)
4.2.10 Other IR market estimates and forecast, 2014 - 2025 (USD Billion)
4.3 Extended-Release/Long-Acting Opioid
4.3.1 Extended-release/long-acting opioid market, 2014 - 2025 (USD Billion)
4.3.2 Oxycodone market estimates and forecast, 2014 - 2025 (USD Billion)
4.3.3 Hydrocodone market estimates and forecast, 2014 - 2025 (USD Billion)
4.3.4 Methadone market estimates and forecast, 2014 - 2025 (USD Billion)
4.3.5 Fentanyl market estimates and forecast, 2014 - 2025 (USD Billion)
4.3.6 Morphine market estimates and forecast, 2014 - 2025 (USD Billion)
4.3.7 Oxymorphone market estimates and forecast, 2014 - 2025 (USD Billion)
4.3.8 Tapentadol market estimates and forecast, 2014 - 2025 (USD Billion)
4.3.9 Buprenorphine market estimates and forecast, 2014 - 2025 (USD Billion)
4.3.10 Hydromorphone market estimates and forecast, 2014 - 2025 (USD Billion)
4.3.11 Other ER market estimates and forecast, 2014 - 2025 (USD Billion)

Chapter 5 Global Opioids Market: Application Estimates & Trend Analysis
5.1 Global opioids market: Application movement analysis
5.2 Pain Relief
5.2.1 Pain relief market estimates and forecast, 2014 - 2025 (USD Billion)
5.2.2 Cancer pain
5.2.2.1 Cancer pain market estimates and forecast, 2014 - 2025 (USD Billion)
5.2.3 Postoperative pain management
5.2.3.1 Postoperative pain management market estimates and forecast, 2014 - 2025 (USD Billion)
5.2.4 Low back pain
5.2.4.1 Low back pain market estimates and forecast, 2014 - 2025 (USD Billion)
5.2.5 Orthopedic
5.2.5.1 Orthopedic market estimates and forecast, 2014 - 2025 (USD Billion)
5.2.6 Neuropathic pain
5.2.6.1 Neuropathic pain market estimates and forecast, 2014 - 2025 (USD Billion)
5.2.7 Fibromyalgia
5.2.7.1 Fibromyalgia market estimates and forecast, 2014 - 2025 (USD Billion)
5.3 Anesthesia
5.3.1 Anesthesia market estimates and forecast, 2014 - 2025 (USD Billion)
5.4 Cough suppression
5.4.1 Cough suppression market estimates and forecast, 2014 - 2025 (USD Billion)
5.5 Diarrhea Suppression
5.5.1 Diarrhea suppression market estimates and forecast, 2014 - 2025 (USD Billion)
5.6 Deaddiction
5.6.1 Deaddiction market estimates and forecast, 2014 - 2025 (USD Billion)

Chapter 6 Global Opioids Market: Regional Estimates & Trend Analysis
6.1 Global opioids market share by region, 2015 & 2025 (USD Billion)
6.2 North America
6.2.1 North America opioids market, 2014 - 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. opioids market, 2014 - 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada opioids market, 2014 - 2025 (USD Billion)
6.3 Europe
6.3.1 Europe opioids market, 2014 - 2025 (USD Billion)
6.3.2 U.K.
6.3.3 U.K. opioids market, 2014 - 2025 (USD Billion)
6.3.4 Germany
6.3.5 Germany opioids market, 2014 - 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific global opioids market, 2014 - 2025 (USD Billion)
6.4.2 Japan
6.4.3 Japan opioids market, 2014 - 2025 (USD Billion)
6.4.4 China
6.4.5 China opioids market, 2014 - 2025 (USD Billion)
6.4.6 India
6.4.7 India opioids market, 2014-2025 (USD Billion)
6.5 Latin America
6.5.1 Latin America opioids market, 2014 - 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil opioids market, 2014 - 2025 (USD Billion)
6.5.3 Mexico
6.5.3.1 Mexico global opioids market, 2014 - 2025 (USD Billion)
6.6 MEA
6.6.1 MEA opioids market, 2014 - 2025 (USD Billion)
6.6.2 South Africa
6.6.3 South Africa Opioids market, 2014 - 2025 (USD Billion)

Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Purdue Pharma L.P.
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Financial performance, by product, 2014 (USD Million)
7.3.1.4 Product benchmarking
7.3.1.5 Strategic initiatives
7.3.2 Janssen Pharmaceuticals, Inc.
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 West-Ward Pharmaceuticals Corporation
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Pfizer, Inc.
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Allergan Plc (Actavis)
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Sanofi-Aventis S.A.
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Sun Pharmaceutical Industries Limited
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Egalet Corporation
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.4 List of Market Players


List of Tables

Table 1 Country share estimation
Table 2 North America opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 3 North America IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 4 North America ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 5 North America opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 6 North America pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 7 U.S. opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 8 U.S. IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 9 U.S. ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 10 U.S. opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 11 U.S. pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 12 Canada opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 13 Canada IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 14 Canada ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 15 Canada opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 16 Canada pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 17 Europe opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 18 Europe IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 19 Europe ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 20 Europe opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 21 Europe pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 22 U.K. opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 23 U.K. IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 24 U.K. ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 25 U.K. opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 26 U.K. pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 27 Germany opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 28 Germany IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 29 Germany ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 30 Germany opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 31 Germany pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 32 Asia Pacific opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 33 Asia Pacific IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 34 Asia Pacific ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 35 Asia Pacific opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 36 Asia Pacific pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 37 Japan opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 38 Japan IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 39 Japan ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 40 Japan opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 41 Japan pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 42 China opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 43 China IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 44 China ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 45 China opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 46 China pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 47 India opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 48 India IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 49 India ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 50 India opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 51 India pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 52 Latin America opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 53 Latin America IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 54 Latin America ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 55 Latin America opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 56 Latin America pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 57 Brazil opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 58 Brazil IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 59 Brazil ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 60 Brazil opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 61 Brazil pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 62 Mexico opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 63 Mexico IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 64 Mexico ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 65 Mexico opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 66 Mexico pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 67 MEA opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 68 MEA IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 69 MEA ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 70 MEA opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 71 MEA pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 72 South Africa opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 73 South Africa IR opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 74 South Africa ER opioids market estimates and forecasts, by product, 2014 - 2025 (USD Billion)
Table 75 South Africa opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)
Table 76 South Africa pain relief opioids market estimates and forecasts, by application, 2014 - 2025 (USD Billion)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary
FIG. 6 Market trends &outlook
FIG. 7 Market segmentation & scope
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Market restraint relevance analysis (Current & future impact)
FIG. 10 Penetration & growth prospect mapping
FIG. 11 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 12 Porter’s Five Forces Analysis
FIG. 13 Global opioids market product outlook
FIG. 14 Global opioids market: Product movement analysis
FIG. 15 Immediate-release/short-acting opioid market, 2014 - 2025 (USD Billion)
FIG. 16 Codeine market, 2014 - 2025 (USD Billion)
FIG. 17 Oxycodone market, 2014 - 2025 (USD Billion)
FIG. 18 Hydrocodone market, 2014 - 2025 (USD Billion)
FIG. 19 Fentanyl market, 2014 - 2025 (USD Billion)
FIG. 20 Morphine market, 2014 - 2025 (USD Billion)
FIG. 21 Hydroxymorphone market, 2014 - 2025 (USD Billion)
FIG. 22 Oxymorphone market, 2014 - 2025 (USD Billion)
FIG. 23 Propoxyphene market, 2014 - 2025 (USD Billion)
FIG. 24 Other IR market, 2014 - 2025 (USD Billion)
FIG. 25 Extended-release/long-acting opioid market, 2014 - 2025 (USD Billion)
FIG. 26 Oxycodone market, 2014 - 2025 (USD Billion)
FIG. 27 Hydrocodone market, 2014 - 2025 (USD Billion)
FIG. 28 Methadone market, 2014 - 2025 (USD Billion)
FIG. 29 Fentanyl market, 2014 - 2025 (USD Billion)
FIG. 30 Morphine market, 2014 - 2025 (USD Billion)
FIG. 31 Oxymorphone market, 2014 - 2025 (USD Billion)
FIG. 32 Tapentadol market, 2014 - 2025 (USD Billion)
FIG. 33 Buprenorphine market, 2014 - 2025 (USD Billion)
FIG. 34 Hydromorphone market, 2014 - 2025 (USD Billion)
FIG. 35 Other ER market, 2014 - 2025 (USD Billion)
FIG. 36 Global opioids Market Application outlook key takeaways
FIG. 37 Global opioids market: End-User movement analysis
FIG. 38 Pain relief market, 2014 - 2025 (USD Billion)
FIG. 39 Cancer pain market, 2014 - 2025 (USD Billion)
FIG. 40 Postoperative pain management market, 2014 - 2025 (USD Billion)
FIG. 41 Low back pain market, 2014 - 2025 (USD Billion)
FIG. 42 Orthopedic market, 2014 - 2025 (USD Billion)
FIG. 43 Neuropathic pain market, 2014 - 2025 (USD Billion)
FIG. 44 Fibromyalgia market, 2014 - 2025 (USD Billion)
FIG. 45 Anesthesia market, 2014 - 2025 (USD Billion)
FIG. 46 Global Cough suppression market, 2014 - 2025 (USD Billion)
FIG. 47 Diarrhea suppression market, 2014 - 2025 (USD Billion)
FIG. 48 Deaddiction market, 2014 - 2025 (USD Billion)
FIG. 49 Regional market place: Key takeaways
FIG. 50 Regional outlook, 2015 & 2025
FIG. 51 North America opioids market, 2014 - 2025 (USD Billion)
FIG. 52 U.S. opioids market, 2014 - 2025 (USD Billion)
FIG. 53 Canada opioids market, 2014 - 2025 (USD Billion)
FIG. 54 Europe opioids market, 2014 - 2025 (USD Billion)
FIG. 55 U.K. opioids market, 2014 - 2025 (USD Billion)
FIG. 56 Germany opioids market, 2014 - 2025 (USD Billion)
FIG. 57 Asia Pacific opioids market, 2014 - 2025 (USD Billion)
FIG. 58 Japan Opioids market, 2014 - 2025 (USD Billion)
FIG. 59 China Opioids market, 2014 - 2025 (USD Billion)
FIG. 60 India Opioids market, 2014 - 2025 (USD Billion)
FIG. 61 Latin America opioids market, 2014 - 2025 (USD Billion)
FIG. 62 Brazil opioids market, 2014 - 2025 (USD Billion)
FIG. 63 Mexico global opioids market, 2014 - 2025 (USD Billion)
FIG. 64 MEA opioids market, 2014 - 2025 (USD Billion)
FIG. 65 South Africa Opioids market, 2014 - 2025 (USD Billion)
FIG. 66 Strategy framework
FIG. 67 Participant categorization
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Purdue Pharma L.P.
  • Janssen Pharmaceuticals, Inc.
  • West-Ward Pharmaceuticals Corporation
  • Pfizer, Inc.
  • Allergan Plc (Actavis)
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Limited
  • Egalet Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll